It looks like you have an older browser that is not supported by this site. Please click here to update.
The Centers for Disease Control and Prevention (CDC) has issued Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States includes information related to TB testing (pages 9-10).
Inactive vaccines do not interfere with tuberculosis (TB) test results. For healthcare personnel or patients who require baseline TB testing (at onboarding or entry into facilities) at the same time they are to receive an mRNA COVID-19 vaccine:
Annual TB testing of residents should wait until four weeks after the individual has received the second dose of COVID-19 vaccine.